Open Access   Special Issue    Topic

Thrombosis in COVID‐19 patients

  • Special Issue Description
  • Keywords
  • Manuscript Submission information
  • Published Articles
  •   This special issue belongs to

      Research & Reviews: Journal of Oncology and Hematology

      Related section


      Deadline for Manuscript Submission

      March 31st, 2023

      Deadline for Publication

      April 15, 2023

    Special Issue Description

    Dear Collegues,

    Covid sickness 2019 (COVID-19) habitually brings about a hypercoagulable expression that is unequivocally connected with mortality. Microvascular and macrovascular thromboembolic or in situ thrombotic complexities have been seen in COVID-19 in the vasculature of the lungs, spleen, cerebrum, stomach, and periphery. There are reports of regular clots development in hemodialysis circuits, strokes as an introducing highlight in youthful patients who were beforehand sound, and blood vessel and venous thromboembolism arrangement notwithstanding prophylactic or completely helpful anticoagulation.

    Besides, thromboses have been recognized both in the intense setting and soon after basic sickness, recommending that the favorable to the thrombotic state could most recent a little while or significantly longer post-hospitalization. Comparable thrombotic entanglements were seen in severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Numerous patients with COVID-19 have given intense ischemic stroke or experienced a stroke while hospitalized, including youthful patients under 50 years of age with generally hardly any previous gamble factors. The rate of stroke in ICU patients has been roughly 2.5% in a few COVID-19 cohorts. Mesenteric ischemia, peripheral artery obstruction, and enormous vessel arteriosclerosis obliterans have likewise been reported, as has cerebral venous sinus thrombosis.

    Thrombotic complications are successive in COVID-19 and altogether add to mortality and horribleness. As Pulmonary Embolism (PE) has been generally seen in a few examination series, the event of intense PE might make sense of certain instances of unexpected right ventricular dysfunction cardiogenic shock, and abrupt demise notwithstanding troponin rise. Whether long-haul complications, for example, aspiratory hypertension might entangle present COVID recuperation stays to be seen. A few thrombogenic systems are possibly ensnared in COVID-19 apoplexy, including apoplexy set off by cytokine storm, antiphospholipid immune response disorder, macrophage activation syndrome, supplement outpouring, and RAS dysregulation.


    * COVID-19
    * Mortality
    * Thrombotic
    * Severe acute respiratory syndrome (SARS)
    * Middle East Respiratory Syndrome (MERS)
    * Cardiogenic Shock
    * Pulmonary Embolism (PE)

    Manuscript Submission information

    Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
    Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.
    Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

    Published articles

    "This special issue is now open for submission."